NOMOS Radiation Oncology, a Division of North American Scientific, will introduce the recently FDA-cleared BATCAM Multi-probe, its new IGRT solution. The system integrates a new multiprobe-capable ultrasound system into the company's core IGRT product, BATCAM. This new system will come standard with an updated abdominal ultrasound probe featuring color doppler ultrasound enabling IGRT for liver and pancreas treatments in addition to prostate and GYN. Optionally the system will be equipped with a bi-planar rectal probe for prostate volume studies and prostate brachytherapy and a wideband, linear probe for verification of Accelerated Partial Breast Irradiation (APBI) brachytherapy devices such as ClearPath. This new device is expected to offer greater utility in addition to expanded clinical IGRT use. BATCAM Multi-probe is expected to be available for shipment in early August.
NOMOS Introduces BATCAM Multi-probe for IGRT
Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carri Glide-Hurst, Ph.D., director of translational research, radiation oncology.